Rare diseases
Investigational molecules
Locations
Study on Long-Term Safety of Ianalumab for Patients with Systemic Lupus Erythematosus
BulgariaStudy on the Effects and Safety of Ianalumab in Adults with Lupus Nephritis Who Completed Previous Treatment
CzechiaStudy on the Effectiveness and Safety of Ianalumab for Patients with Diffuse Cutaneous Systemic Sclerosis
AustriaPhase III trial evaluating ianalumab with background drug combination in patients with Sjögren's disease
AustriaPhase 3 study of ianalumab plus standard drug combination in adults and adolescents with systemic lupus erythematosus
BulgariaStudy of ianalumab for adults with primary immune thrombocytopenia or warm-antibody autoimmune hemolytic anemia who previously responded to ianalumab
BelgiumA Study of Ianalumab and Eltrombopag for Patients with Primary Immune Thrombocytopenia Who Did Not Respond Well to or Relapsed After Steroid Treatment
AustriaStudy on the Effects of Ianalumab in Patients with Sjögren's Syndrome
FranceStudy on the Effects of Ianalumab with Standard Therapy for Patients with Active Lupus Nephritis
CzechiaStudy on the Effects of Ianalumab in Adults with Rheumatoid Arthritis, Systemic Lupus Erythematosus, or Sjögren’s Disease
CzechiaStudy on the Effects of VAY736 for Patients with Autoimmune Hepatitis Who Do Not Respond Well to Standard Treatment
CzechiaStudy on the Effectiveness of Ianalumab for Treating Moderate to Severe Hidradenitis Suppurativa in Patients
AustriaTell us about your condition – we search every trial in Europe and connect you with the right site.
